A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
In a 2023 position statement, the Menopause Society recommended clinical hypnosis for vasomotor symptoms, and other randomized trials have shown that therapist-delivered hypnosis can reduce the ...
A new clinical trial led by Baylor University’s Gary R. Elkins, Ph.D., professor of psychology and neuroscience, found that ...
A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their ...
A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. This is an ...
Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer Patients age 20 years and ...